12 June 2019 - The Cancer Drugs Fund was established in 2010 to improve access to treatments not routinely available. Having widely overspent, stricter budgeting rules were introduced in 2016.
The Cancer Drugs Fund (CDF) can now only include treatments with potential to be cost effective once sufficient data are collected.
The objective of Sabry-Grant et al. was to explore the process and criteria used for consideration of treatments under the new CDF framework and to describe the extent of evidence collection.